By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Pew PatriotsPew PatriotsPew Patriots
Notification Show More
Font ResizerAa
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Reading: FDA approves first twice-yearly injection that prevents HIV infection
Share
Font ResizerAa
Pew PatriotsPew Patriots
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Search
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Have an existing account? Sign In
Follow US
FDA approves first twice-yearly injection that prevents HIV infection
News

FDA approves first twice-yearly injection that prevents HIV infection

Jimmie Dempsey
Last updated: June 19, 2025 1:06 pm
Jimmie Dempsey Published June 19, 2025
Share
SHARE

NEWYou can now listen to Fox News articles!

The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent HIV, the creator of the drug, Gilead Sciences, announced on Wednesday.

Sold under the name Yeztugo, the company’s injectable HIV-1 capsid inhibitor (lenacapavir) reduces the risk of sexually acquired HIV in adults and adolescents.

“This is a historic day in the decades-long fight against HIV,” said Daniel O’Day, chairman and CEO of California-based Gilead Sciences, in a press release.

ALZHEIMER’S DISEASE COULD BE PREVENTED BY ANTIVIRAL DRUG ALREADY ON MARKET

The medicine, which only needs to be administered twice a year, has shown “remarkable outcomes in clinical studies,” as Gilead claims it could transform HIV prevention.

The drug is given as an injectable under the skin that the body then slowly absorbs. Individuals must have a negative HIV-1 test prior to starting the treatment.

In large trials last year, the drug was not only nearly 100% effective in its prevention of HIV, but proved superior to once-daily oral medication like Truvada, another drug by Gilead.

A pharmacist holds a vial of lenacapavir

The journal Science named lenacapavir its 2024 “Breakthrough of the Year.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Lenacapavir uses a multi-stage approach that distinguishes it from other approved antiviral medications. 

Man at doctor's appointment

“While most antivirals act on just one stage of viral replication, lenacapavir is designed to inhibit HIV at multiple stages of its lifecycle,” states the press release from Gilead.

For more Health articles, visit www.foxnews.com/health

“Yeztugo is one of the most important scientific breakthroughs of our time and offers a very real opportunity to help end the HIV epidemic,” O’Day said in the press release.

The most commonly reported adverse reactions during clinical trials included injection site reactions, headache and nausea, according to the company.

Read the full article here

You Might Also Like

White House displays lawn signs highlighting illegal immigrant crime

America’s energy crisis is hiding in plain sight and it’s worse than you know

Shooter who opened fire on Border Patrol agents in South Texas identified by police chief

Human Rights Council blocks watchdog chief from criticizing UN official accused of antisemitism

Oliver Anthony calls for personal responsibility, revival: ‘We don’t need our false idols’

Share This Article
Facebook Twitter Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

We Recommend
Former public school teacher, 33, charged after ‘prolonged pattern of abuse’ with teen boy
News

Former public school teacher, 33, charged after ‘prolonged pattern of abuse’ with teen boy

Jimmie Dempsey Jimmie Dempsey July 11, 2025
Ohio boy crawls into claw machine, gets stuck, rescued with pride bruised but unharmed
White House again defends success of B-2 raid on Iran amid new report some uranium survived
State Department to begin mass layoffs of about 1,800 employees in coming days
Chargers’ Najee Harris sustains ‘superficial eye injury’ during fireworks mishap at holiday event, agent says
Missing teen surfer found alive on remote island miles from shore: ‘Didn’t give up hope’
50 Survival Supplies to Look for at the Grocery Store
Prepping & Survival

50 Survival Supplies to Look for at the Grocery Store

Jimmie Dempsey Jimmie Dempsey July 11, 2025
Ammo Prices Just Crashed, But Nobody’s Buying. Here’s Why.
TacticalVideos

Ammo Prices Just Crashed, But Nobody’s Buying. Here’s Why.

Line45 Line45 July 11, 2025
Canadian police official warns ‘traditional values’ may be sign a person is becoming ‘extremist’
News

Canadian police official warns ‘traditional values’ may be sign a person is becoming ‘extremist’

Jimmie Dempsey Jimmie Dempsey July 11, 2025
Pew Patriots
  • News
  • Tactical
  • Prepping & Survival
  • Videos
  • Guns and Gear
2024 © Pew Patriots. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?